1. TVC Research & Testing Report, Paddy Boylan 8.9.13

Embed Size (px)

Citation preview

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    1/20

    "

    -PDV Research Services-

    !"#"$!%& !"()!*

    +,-,./

    %01"2*3 #$% &'()*

    (!)4"%* &"$53 +,--. &(.',/

    (!)4"%* 2678"!3 "0"12

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    2/20

    2

    %)2*"2*#

    3456789:5;74

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    3/20

    0

    12*!)56%*1)2

    N@A O7FF7P;4L 6ABAI6:@ PIB :7489:5A8 57 AQIF9I5A 5@A :966A45 AOOA:5;QA4ABB 7O #$%&F7:RSB !"#$%& () *)#$%&+NT) 57 8A5A6H;4A K75@ 5@A I98;A4:ASB FAQAF 7O ?6AQ;79BAM?7B96A 57 5@A I8 I48 57 :7H?I6A 6AB?74BAB IH74L HAIB96A8 8AH7L6I?@;:B=

    N@A I8 ?67H75AB #$% &F7:RSB BA6Q;:AB ;4 5IMI5;74 I::7945;4L= (4A ?6A8;:576 7O 5@AAOOA:5;QA4ABB 7O 5@;B I8 PIB 57 5AB5 5@A I8SB I??AIF I48 B9::ABB ;4 HABBILA:7HH94;:I5;74 ;4 5@A I::7945;4L BA6Q;:A ;489B56>SB HI;4 8AH7L6I?@;:BU 8I5I 74 P@;:@PIB 8A5A6H;4A8 5@679L@ %7> D76LI4V

    WXBILA 7O O;4I4:;IF ?FI44A6B I??AI6B 57 ;4:6AIBA B5AI8;F> P;5@ ILAU P;5@ I??67M;HI5AF>@IFO 7O IFF ?A7?FA ILA8 GEY @IQ;4L 9BA8 I O;4I4:;IF ?FI44A6ZI8Q;B76 76 I::7945I45 577K5I;4 5@A;6 PAIF5@ HI4ILAHA45 ?6789:5=W"

    ,88;5;74IFF>VW[@;FB5 P7HA4 PA6A FABB F;RAF> 5@I4 HA4 57 9BA I O;4I4:;IF ?FI44A6 I:67BB H7B5 ILAL679?B I48 ?I65;:9FI6F> IH74L 5@7BA ILA8 E\]GC >AI6BU 5@;B PIB 475 B7 IH74L ?A7?FAILA8 GEY >AI6B=W"

    /75A 5@I5 5@A 6A?765 5@ABA ^975AB I6A 86IP4 O67H 9BAB 5@A 5A6HB ,"-.-/".% $%.--&0I48.//)1-(.-( ;45A6:@I4LAIKF>=

    N@;B :766AB?748B P;5@ 8I5I O67H 5@A 2"3"-4 "- 516(0.%". F74L;598;4IF B96QA>U P@;:@B@7PB I HI5:@;4L ;4:6AIBA 57 ;48;Q;89IF 4A5 P765@ P;5@ ILA2_BAA 5IKFA G=\ ;4 5@AI??A48;M`=

    N7 B9HHI6;BA 5@;B 8I5IV

    ] XBA 7O I::7945;4L BA6Q;:AB ;4:6AIBAB P;5@ 5@A ILA 7O 5@A 8AH7L6I?@;:=] DA4 948A6 GE >AI6B 5A48 57 9BA I::7945;4L BA6Q;:AB BF;L@5F> H76A 5@I4 P7HA4

    7O 5@A BIHA ILA=] XBILA 7O O;4I4:;IF BA6Q;:AB B?;RAB ;4 HA4 I48 P7HA4 7QA6 GEU P;5@ P7HA4 9B;4L

    BF;L@5F> H76A 5@I4 HA4=

    "DA4 H76A F;RAF> 5@I4 P7HA4 57 7K5I;4 [AIF5@ DI4ILAHA45 ?6789:5B Q;I O;4I4:;IF ?FI44A6B76 I::7945I45B ] %7> D76LI4 %ABAI6:@= 2\"0= a(/'3/bc ,QI;FIKFA I5V@55?VZZPPP=67>H76LI4=:7HZO;48;4LBZHA4]H76A]F;RAF>]7K5I;4]PAIF5@]HI4ILAHA45]?6789:5B]

    2\"0\E"G\\22= a,::ABBA8 \" dA?5AHKA6 2\"0c=234:7HA I48 PAIF5@ e ';Q;4L ;4 ,9B56IF;I= 2\"0= a(/'3/bc ,QI;FIKFA I5V

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    4/20

    C

    &9()*&"#"#

    [A KAL;4 P;5@ 5P7 HI;4 #>?75@ABABV

    "= [A ?6A8;:5A8 5@I5 ?6AQ;79B AM?7B96A 57 5@;B 5@;B I8 P79F8 KA 6A:IFFA8 I48 ;5SB K6I48I48 HABBILA :7H?6A@A48A8 K> ?A7?FA :;

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    5/20

    E

    7"*&)5

    "= %ABAI6:@ KALI4 P;5@ I K67I8]8AH7L6I?@;: B96QA> ;4 768A6 57 LI5@A6 I 8;QA6BA 8I5IBA5 74 P@;:@ 57 5AB5 5@A ILA I48 LA48A6 8A?A48A45 I556;K95AB 7O 796 @>?75@ABAB= 35 PIB

    8;B56;K95A8 57 7QA6 C\\ ;48;Q;89IFB O67H 796 HI;F;4L F;B5 7QA6 gI:AK77R I48 AHI;F=

    N@A B96QA> IBRA8 6AB?748A45B 57 Q;AP 5@A I8 K> O7FF7P;4L I4 AM5A64IF F;4R 57 gI:AK77RUP@A6A 5@A I8 PIB ?7B5A8 ;4 ;5B 76;L;4IF 0\ BA:748 O76H= [A IBRA8 "\ ^9AB5;74B ;4 575IFU:7QA6;4L 5@A O7FF7P;4LV] -A5A6H;4;4L ILA $ LA48A6 _H9F5;?FAZK;4I6> :@7;:A 6AB?A:5;QAF>`] DAIB96;4L I??AIF _B:IFA8 H9F5;?FA :@7;:A`] DAIB96;4L K6I48ZBA6Q;:A :7H?6A@A4B;74 _7?A4 O;AF8 $ B:IFA8 H9F5;?FA :@7;:A`] NAB5;4L 6A:IFF 7O ?6AQ;79B AM?7B96A _K;4I6> :@7;:A`[A P79F8 F;RA 57 475A 5@I5 89A 57 5@A 4I596A 7O 796 HI;F;4L F;B5 5@A HIh76;5> 7O;48;Q;89IFB 5I6LA5A8 P@A6A ILA8 KA5PAA4 "1 I48 2JU P;5@ 49HKA6B 5I?A6;4L 7OO P;5@;4:6AIBA8 ILA= N@A 795:7HA 7O 5@;B BRAP ;B 8;B:9BBA8 ;4 5@;B 6A?765SB 6AB9F5B=

    2= i9IF;5I5;QA 8I5I PIB LI5@A6A8 ;4 5@A O76H 7O I O7:9B L679? 7O "0 ;48;Q;89IFBU P@;:@KALI4 P;5@ I B:6AA4;4L 7O 5@A I8= ,B PAFF IB 57 O965@A6 5AB5 796 @>?75@AB;BU 5@ABA;45A6Q;APB ?67Q;8A8 ;4B;L@5B ;457 P@> I98;A4:AB 6AB?748A8 5@A PI> 5@A> 8;8=

    N@A O7:9B L679? :74B;B5A8 7O HIFAB I48 OAHIFAB I:67BB I 6I4LA 7O ILA I48 A5@4;:KI:RL67948BU IFF7P;4L ?75A45;IF O76 I QI6;A5> 7O ;4B;L@5B I:67BB I K67I8 :74B9HA6 KIBA=

    #7PAQA6U 5@A L679? @I8 5P7 B9K]7?5;HIF 8AH7L6I?@;: K;IBAB= N@A6A PIB 47 74A6A?6ABA45;4L 5@A ;H?765I45 ILA GE I48 7QA6 :74B9HA6 :I5AL76>U I48 5@A L679?U HI;4F>B598A45BU LA4A6IFF> AI64A8 948A6 jCJUJJJ ?A6 >AI6= N@ABA K;IBAB P@A6A 5IRA4 ;457:74B;8A6I5;74 H7Q;4L O76PI68U I48 I6A O965@A6 8;B:9BBA8 ;4 5@A 6AB9F5B=

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    6/20

    G

    !"#60*#

    ,= [@A4 :7H?I6;4L BA:748I6> 8I5I IK795 ILA I48 I::7945;4L BA6Q;:AB 9BA P;5@796 B96QA> 8I5I IK795 ILA I48 K6I48 6A:7L4;5;74ZBA6Q;:A :7H?6A@A4B;74U PAO7948 47 B5674L :766AFI5;74B= %AOA6 57 5IKFAB "=\ $ "=" ;4 5@A I??A48;M=

    &= N@A6A PIB I BF;L@5 :766AFI5;74 ;4 796 B96QA> KA5PAA4 LA48A6 I48 K6I486A:7L4;5;74ZBA6Q;:A :7H?6A@A4B;74 6ALI68FABB 7O ILA= N@A O7FF7P;4L L6I?@B:7H?I6A 6AB?74BAB 7O IL6AAHA45 57 5@A O7FF7P;4L B5I5AHA45V

    78 0&/)4-"9& (:& ;0.-< .-< 1-8;BIL6AA

    Cf

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    7/20

    k

    -= ,98;A4:AB ILA8 CEY 6AB?748A8 KAB5 P@A4 :7H?I6A8 57 I98;A4:AB ILA8 "1]0C=/75A 5@I5 47 B96QA> 8I5I PIB LI5@A6A8 O76 ILAB 0E]CC= N@A O7FF7P;4L L6I?@B:7H?I6A I 6I4LA 7O 6AB?74BAB KA5PAA4 5@A 5P7 L679?BV

    FHIJC

    CKL

    @A:&6& 40.$:6 .0& ,)1-< .4."- "- (:& 5$$&-

    N@79L@5 PIB AOOA:5;QA

    N@79L@5 PIB HAH76IKFA

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    8/20

    1

    b= N@A O7:9B L679? 6AQAIFA8 LA4A6IFF> ?7B;5;QA OAAF;4LB 57PI68B 5@A I8= i975AB;4:F98AV

    o lN@A> HI8A ;5 B;H?FA I48 O944>=mo l_35 HI8A HA 5@;4R` #$% &F7:R :I4 87 5IM ;4 5@A;6 BFAA?=mo l35SB HIR;4L B7HA5@;4L QA6>< 94HAH76IKFAU K76;4LU B7HA5@;4L 3 874S5

    PI45 57 AQA4 5@;4R IK795< ^9;5A HAH76IKFA=mo l35 HI8A HA 5@;4R IK795 _9B;4L #$% &F7:R ;4 5@A O9596A`=m

    g= N@A O7:9B L679? LA4A6IFF> 6A:IFFA8 BAA;4L 5@A I8 I5 FAIB5 74:A KAO76A= N@A>LA4A6IFF> 6A:IFFA8 BAA;4L QI6;I5;74B ;4 5@A I8U F;R;4L I48 6A:IFF;4L 5@A l8;OOA6A4556;:RBm 5@A K;RA 6;8A6 ?A6O76HB= N@A> LA4A6IFF> I:R47PFA8LA8 5@I5 ;5 @I8 KAA46944;4L O76 I67948 I >AI6=

    n= N@A L679? :79F8 6A:IFF 47 75@A6 K6I48BS I8B O76 5IMI5;74 BA6Q;:AB= N7 ^975A 74A;48;Q;89IFV

    l 75@A6 5IM :7H?I4;AB 87 >79 BAA I8QA65;B;4Lom_d5I5A8 IB I 6@A576;:IF ^9AB5;74`

    (4F> 74A L679? HAHKA6 :79F8 6A:IFF 75@A6 K6I48B 5@I5 7OOA6A8 5IMI5;74 BA6Q;:AB=

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    9/20

    J

    %)2%06#1)2 B !"%)77"25$*1)2#

    &AO76A I4IF>B;4L 5@A 6AB9F5BU 5@A O7FF7P;4L ?7;45B B@79F8 KA 5IRA4 ;457 :74B;8A6I5;74V

    C -9A 57 I4 A6676 ;4 B96QA> 8AB;L4U ILA 8AH7L6I?@;: L679?;4LB KAL;4 P;5@ FHIMCU5@A4 ;4:6AIBA ;4 "\]>AI6 KF7:RB _MKIJCU JKICCA5:=` 9? 57 NKL_BAA NIKFA " ;4 5@A,??A48;M`= N@;B 87AB 475 A45;6AF> IF;L4 P;5@ 5@A ILA L679?;4L 7O 796 ?6;HI6>B796:A 7O BA:748I6> 8I5IC= dAA NIKFA " ;4 5@A ,??A48;M=

    ] N@A B96QA> 6AB9F5B OAI596A8 I @AIQ> BRAP 57PI68B 6AB?748A45B ILA8 "1]2JUP;5@ QA6> OAP 7F8A6 ;48;Q;89IFB 6AB?748;4L= dAA NIKFA 2 ;4 5@A ,??A48;M=

    ] (4F> 74A 6AB?748A45 ;4 5@A ILA GEY :I5AL76> 8AB;L4I5A8 O76 ;45A6Q;AP PIBIQI;FIKFA=

    #>?75@AB;B "Vl[A ?6A8;:5A8 5@I5 5@;B I8 P79F8 KA 6A:IFFA8 I48 :7H?6A@A48A8 K> ?A7?FA

    ?67?765;74I5A 57 @7P PAFF 5@A> O;5 ,::7945;4L dA6Q;:ASB HI;4 HI6RA5U IB 5@;B8A5A6H;4AB 5@A 6AFAQI4:> 7O ,::7945;4L dA6Q;:AB 57 5@A;6 7P4 F;QAB=m

    N@A 8I5I LI5@A6A8 B@7PB 74F> I KIB;: :766AFI5;74U I48 ;4 ILAB "1]0C 74F>U KA5PAA4 ILAI48 K6I48 6A:7L4;5;74ZBA6Q;:A :7H?6A@A4B;74=

    N@A6A PIB B7HA BF;L@5 ;48;:I5;74 5@I5 HA4 @I8 KA55A6 K6I48 6A:7L4;5;74ZBA6Q;:A:7H?6A@A4B;74 5@I4 P7HA4= dAA %AB9F5 &U I48 5IKFAB C=\]C="=

    #7PAQA6U 89A 57 5@A FI:R 7O B96QA> 8I5I ?7;45B ;4 ILAB 0EYU PA KAF;AQA PA 87 475 @IQAA479L@ ;4O76HI5;74 57 6AI:@ I4> B96A :74:F9B;74 IK795 @>?75@AB;B "=

    %A:IFF 7O ?6AQ;79B I8 AM?7B96A LA4A6IFF>U @7PAQA6U PIB AM:AFFA45= [A :;5A 5@A O7FF7P;4L8I5IV

    ] %AB9F5 O IK7QA=] NIKFA "=" ;4 5@A I??A48;M=] NIKFA 0=0 ;4 5@A I??A48;M=] NIKFAB C=\ p C="=

    CDA4 H76A F;RAF> 5@I4 P7HA4 57 7K5I;4 [AIF5@ DI4ILAHA45 ?6789:5B Q;I O;4I4:;IF ?FI44A6B76 I::7945I45B ] %7> D76LI4 %ABAI6:@= 2\"0= a(/'3/bc ,QI;FIKFA I5V@55?VZZPPP=67>H76LI4=:7HZO;48;4LBZHA4]H76A]F;RAF>]7K5I;4]PAIF5@]HI4ILAHA45]?6789:5B]

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    10/20

    "\

    #>?75@AB;B 2VD[A ?6A8;:5A8 5@I5 5@A I8U :745;49;4L 57 694 74A >AI6 IO5A6 ;5SB ;4;5;IF I;6;4LU ;BB5;FF LA4A6IFF> BAA4 OIQ796IKF> K> I98;A4:ABU P;5@ I K;IB 57PI68 7F8A6 I98;A4:AB=[A IFB7 AM?A:5 ?7B;5;QA K;IBAB ;4 HA4 ILA8 0\]GC 89A 57 5@A :745A45 7O 5@A I8=

    (96 B96QA> I48 O7:9B L679? 8I5I 5AFF 9B 5@I5 5@A I8 PIB Q;APA8 OIQ796IKF> K> I K67I8I98;A4:AU P;5@ 47 7KQ;79B K;IB O76 LA48A6= dAA 5IKFAB 0=\ ] 0=0 I48 6AB9F5 b=

    ] ,98;A4:AB 5A48A8 57 F;RA 5@A I8=] N@A> 5A48A8 57 5@;4R ;5 PIB BF;L@5F> O944>=] N@A> 5@79L@5 ;5 PIB OI;6F> AOOA:5;QA=] N@A> 5@79L@5 ;5 PIB OI;6F> HAH76IKFA=

    N@A6A PIB ;48;:I5;74 7O B5674L ?6AOA6A4:A O76 5@A I8 ;4 ILAB CEY 7QA6 ILAB "1]0CU IBAQ;8A4:A8 K> 6AB9F5 - I48 5IKFAB E=\]E="= N@;B PIB AB?A:;IFF> 569A P@A4 ;48;Q;89IFBP@A6A IBRA8 ;O 5@A> 5@79L@5 5@A I8 PIB #)0.;%&=

    &IBA8 9?74 5@ABA O;48;4LBU PA KAF;AQA 5@I5 P@;FA 5@A6A ;B I ?75A45;IF ?I65;IF:74O;6HI5;74 7O @>?75@AB;B 2U IF5@79L@ H76A 8I5I ;B 4AA8A8V

    ] N@A6A PIB B7HA AQ;8A4:A 7O I98;A4:AB CE I48 7QA6 F;R;4L 5@A I8= #7PAQA6 5@A6APIB 47 B96QA>A8 8I5I KA5PAA4 ILAB 0E]CCU I48 P@;FA 5@A B96QA> @I8 EE6AB?748A45B 575IFU 74F> E 7O 5@7BA P@A6A ILA8 7QA6 CE=

    ] N@A6A PIB 47 B9KB5I45;IF ;48;:I5;74 5@I5 HA4 ?6AOA66A8 5@A I8 57 P7HA4=!AE

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    11/20

    ""

    81801)M!$(&9

    .N 34:7HA I48 PAIF5@ e ';Q;4L ;4 ,9B56IF;I= a(/'3/bc ,QI;FIKFA I5V@55?VZZPPP=F;Q;4L;4I9B56IF;I=76LZ6AB9F5BZ;4:7HA]PAIF5@=@5HF= a,::ABBA8 \"dA?5AHKA6 2\"0c

    +N DA4 H76A F;RAF> 5@I4 P7HA4 57 7K5I;4 [AIF5@ DI4ILAHA45 ?6789:5B Q;IO;4I4:;IF ?FI44A6B 76 I::7945I45B ] %7> D76LI4 %ABAI6:@= 2\"0= a(/'3/bc,QI;FIKFA I5V @55?VZZPPP=67>H76LI4=:7HZO;48;4LBZHA4]H76A]F;RAF>]7K5I;4]PAIF5@]HI4ILAHA45]?6789:5B]2\"0\E"G\\22= a,::ABBA8 \" dA?5AHKA6 2\"0c

    ,88;5;74IF HI5A6;IFV

    !"#$%& () *)#$%&+NT) IQI;FIKFA O76 Q;AP;4L I5V@55?BVZZPPP=>7959KA=:7HZPI5:@oQq*XNr+sR^]bP

    ,98;7 7O 5@A O7:9B L679? IQI;FIKFA I5V@55?BVZZB7948:F798=:7HZABRIFI5ZO7:9B]L679?]2k]1]"0

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    12/20

    "2

    $(("251O

    @5%% D T 5//)1-("-4 6&03"/&6 16& ;= .4& .-< 4&-F T 7A:& 0&6$)- 5@I4 P7HA4 57 7K5I;4 [AIF5@ DI4ILAHA45 ?6789:5B Q;I O;4I4:;IF ?FI44A6B76 I::7945I45B ] %7> D76LI4 %ABAI6:@= 2\"0= a(/'3/bc ,QI;FIKFA I5V@55?VZZPPP=67>H76LI4=:7HZO;48;4LBZHA4]H76A]F;RAF>]7K5I;4]PAIF5@]HI4ILAHA45]?6789:5B]

    CfGf

    "Gf

    0\f

    C1f

    2fEf

    "2f

    2"f

    E\f

    \=\\f

    "\=\\f

    2\=\\f

    0\=\\f

    C\=\\f

    E\=\\f

    G\=\\f

    "C]2E 2E]0C 0E]CJ E\]GC GEYDIFA gAHIFA

    "1f

    "2f

    \f \f

    "\\f

    \f

    "1f

    "2f

    \f \f \f \f

    GEf

    kGf

    \f

    "\\f

    \f

    "\\f

    \f

    "\f

    2\f

    0\f

    C\f

    E\f

    G\f

    k\f

    1\f

    J\f

    "\\f

    "1]2C 2E]0C 0E]CC CE]EC EE]GC GEY-;BIL6AA 76 d5674LF> -;BIL6AA /A;5@A6 8;BIL6AAZIL6AA ,L6AA 76 d5674LF> ,L6AA

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    13/20

    "0

    A5S2O M>D T 54& 40)1$6 ), 6103&= 0&6$)-D T 7- ./0"& 12" '&?B 0&61%(6 ./0)66 .%% 6103&=&< -;BIL6AAU2f

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    14/20

    "C

    A5S2O J>F T 7- 12$+321 12" '& 4'! 5+%%)?B 0&61%(6 ./0)66 .%% 6103&=&<

    d5674LF>IL6AAU \f

    ,L6AAU C2f

    /A;5@A6IL6AAZ

    8;BIL6AAU 21f

    -;BIL6AAU 2"f

    d5674LF>8;BIL6AAU Gf

    d5674LF>,L6AAU "=12f

    ,L6AAU E2=k0f

    /A;5@A6IL6AAZ

    8;BIL6AAU20=GCf

    -;BIL6AAU2"=12f

    _d5674LF>8;BIL6AA`U \f

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    15/20

    "E

    A5S2O J>J T 7- 12$+321 12" '& 4'! 7"7$('8."?B 0&61%(6 ./0)66 .%% 6103&=&IL6AA22f

    ,L6AAEGf

    /A;5@A6IL6AAZ

    8;BIL6AA""f

    -;BIL6AA""f

    d5674LF>8;BIL6AA

    \f

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    16/20

    "G

    A5S2O K>D T U&./(")-6 () (:& . N@79L@5 PIB AOOA:5;QA N@79L@5 PIB HAH76IKFA

    d5674LF>IL6AA"Jf

    ,L6AAE"f

    /A;5@A6IL6AAZ

    8;BIL6AA"Ef

    -;BIL6AA""f

    d5674LF>8;BIL6AA

    Cf

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    17/20

    "k

    A5S2O K>F T U&./(")-6 () (:& . N@79L@5 PIB AOOA:5;QA N@79L@5 PIB HAH76IKFA

    01\U\\\

    C2\U\\\

    0J\U\\\

    "1\U\\\

    E\U\\\

    j\=\\ j"\\U\\\=\\ j2\\U\\\=\\ j0\\U\\\=\\ jC\\U\\\=\\ jE\\U\\\=\\

    k\Y

    G\]k\

    E\]G\

    C\]E\

    0\]C\

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    18/20

    "1

    d96QA> :6AI5A8 P;5@ I48 8;B56;K95A8 K> !103&=#)-X&=>/)#

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    19/20

    "J

  • 8/13/2019 1. TVC Research & Testing Report, Paddy Boylan 8.9.13

    20/20

    2\